Literature DB >> 30253175

Activation of lateral hypothalamic group III metabotropic glutamate receptors suppresses cocaine-seeking following abstinence and normalizes drug-associated increases in excitatory drive to orexin/hypocretin cells.

Jiann W Yeoh1, Morgan H James2, Cameron D Adams1, Jaideep S Bains3, Takeshi Sakurai4, Gary Aston-Jones5, Brett A Graham1, Christopher V Dayas6.   

Abstract

The perifornical/lateral hypothalamic area (LHA) orexin (hypocretin) system is involved in drug-seeking behavior elicited by drug-associated stimuli. Cocaine exposure is associated with presynaptic plasticity at LHA orexin cells such that excitatory input to orexin cells is enhanced acutely and into withdrawal. These changes may augment orexin cell reactivity to drug-related cues during abstinence and contribute to relapse-like behavior. Studies in hypothalamic slices from drug-naïve animals indicate that agonism of group III metabotropic glutamate receptors (mGluRs) reduces presynaptic glutamate release onto orexin cells. Therefore, we examined the group III mGluR system as a potential target to reduce orexin cell excitability in-vivo, including in animals with cocaine experience. First, we verified that group III mGluRs regulate orexin cell activity in behaving animals by showing that intra-LHA infusions of the selective agonist L-(+)-2-Amino-4-phosphonobutyric acid (L-AP4) reduces c-fos expression in orexin cells following 24 h food deprivation. Next, we extended these findings to show that intra-LHA L-AP4 infusions reduced discriminative stimulus-driven cocaine-seeking following withdrawal. Importantly, L-AP4 had no effect on lever pressing for sucrose pellets or general motoric behavior. Finally, using whole-cell patch-clamp recordings from identified orexin cells in orexin-GFP transgenic mice, we show enhanced presynaptic drive to orexin cells following 14d withdrawal and that this plasticity can be normalized by L-AP4. Together, these data indicate that activation of group III mGluRs in LHA reduces orexin cell activity in vivo and may be an effective strategy to suppress cocaine-seeking behavior following withdrawal. These effects are likely mediated, at least in part, by normalization of presynaptic plasticity at orexin cells that occurs as a result of cocaine exposure. This article is part of the Special Issue entitled 'Hypothalamic Control of Homeostasis'.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Discriminative stimuli; Plasticity; Reinstatement; Withdrawal; mglur

Mesh:

Substances:

Year:  2018        PMID: 30253175      PMCID: PMC6520213          DOI: 10.1016/j.neuropharm.2018.09.033

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  73 in total

Review 1.  Motivational activation: a unifying hypothesis of orexin/hypocretin function.

Authors:  Stephen V Mahler; David E Moorman; Rachel J Smith; Morgan H James; Gary Aston-Jones
Journal:  Nat Neurosci       Date:  2014-09-25       Impact factor: 24.884

2.  Dorsal Hippocampus Drives Context-Induced Cocaine Seeking via Inputs to Lateral Septum.

Authors:  Ellen M McGlinchey; Gary Aston-Jones
Journal:  Neuropsychopharmacology       Date:  2017-07-11       Impact factor: 7.853

3.  Structure and function of human prepro-orexin gene.

Authors:  T Sakurai; T Moriguchi; K Furuya; N Kajiwara; T Nakamura; M Yanagisawa; K Goto
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

4.  Distinct inhibition of acute cocaine-stimulated motor activity following microinjection of a group III metabotropic glutamate receptor agonist into the dorsal striatum of rats.

Authors:  L Mao; J Q Wang
Journal:  Pharmacol Biochem Behav       Date:  2000-09       Impact factor: 3.533

5.  Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats.

Authors:  Stephen V Mahler; Rachel J Smith; Gary Aston-Jones
Journal:  Psychopharmacology (Berl)       Date:  2012-03-13       Impact factor: 4.530

6.  Orexin signaling mediates the antidepressant-like effect of calorie restriction.

Authors:  Michael Lutter; Vaishnav Krishnan; Scott J Russo; Saendy Jung; Colleen A McClung; Eric J Nestler
Journal:  J Neurosci       Date:  2008-03-19       Impact factor: 6.167

7.  Renewal of extinguished cocaine-seeking.

Authors:  A S Hamlin; K J Clemens; G P McNally
Journal:  Neuroscience       Date:  2007-11-28       Impact factor: 3.590

8.  Role of orexin/hypocretin in conditioned sucrose-seeking in female rats.

Authors:  Angie M Cason; Gary Aston-Jones
Journal:  Neuropharmacology       Date:  2014-07-15       Impact factor: 5.250

9.  Orexin neurons function in an efferent pathway of a food-entrainable circadian oscillator in eliciting food-anticipatory activity and wakefulness.

Authors:  Michihiro Mieda; S Clay Williams; Christopher M Sinton; James A Richardson; Takeshi Sakurai; Masashi Yanagisawa
Journal:  J Neurosci       Date:  2004-11-17       Impact factor: 6.167

Review 10.  Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls.

Authors:  Jiann Wei Yeoh; Erin J Campbell; Morgan H James; Brett A Graham; Christopher V Dayas
Journal:  Front Neurosci       Date:  2014-02-25       Impact factor: 4.677

View more
  8 in total

1.  Group III metabotropic glutamate receptors regulate hypothalamic presympathetic neurons through opposing presynaptic and postsynaptic actions in hypertension.

Authors:  Jing-Jing Zhou; Judith Pachuau; De-Pei Li; Shao-Rui Chen; Hui-Lin Pan
Journal:  Neuropharmacology       Date:  2020-05-23       Impact factor: 5.250

2.  The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task.

Authors:  Joost Wiskerke; Morgan H James; Gary Aston-Jones
Journal:  Brain Res       Date:  2019-04-16       Impact factor: 3.252

Review 3.  The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse.

Authors:  Morgan H James; Jennifer E Fragale; Shayna L O'Connor; Benjamin A Zimmer; Gary Aston-Jones
Journal:  Neuropharmacology       Date:  2020-10-19       Impact factor: 5.250

4.  Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil.

Authors:  Aida Mohammadkhani; Morgan H James; Caroline B Pantazis; Gary Aston-Jones
Journal:  Brain Res       Date:  2019-09-14       Impact factor: 3.252

Review 5.  Sleep dysregulation in binge eating disorder and "food addiction": the orexin (hypocretin) system as a potential neurobiological link.

Authors:  Jacqueline B Mehr; Deborah Mitchison; Hannah E Bowrey; Morgan H James
Journal:  Neuropsychopharmacology       Date:  2021-06-18       Impact factor: 7.853

6.  Cocaine-Seeking Behavior Induced by Orexin A Administration in the Posterior Paraventricular Nucleus of the Thalamus Is Not Long-Lasting: Neuroadaptation of the Orexin System During Cocaine Abstinence.

Authors:  Alessandra Matzeu; Rémi Martin-Fardon
Journal:  Front Behav Neurosci       Date:  2021-02-23       Impact factor: 3.558

7.  Electroacupuncture Enhances Neuroplasticity by Regulating the Orexin A-Mediated cAMP/PKA/CREB Signaling Pathway in Senescence-Accelerated Mouse Prone 8 (SAMP8) Mice.

Authors:  Zhitao Hou; Xinyu Yang; Yang Li; Jing Chen; Hongcai Shang
Journal:  Oxid Med Cell Longev       Date:  2022-02-04       Impact factor: 6.543

8.  Circadian Influences on the Habenula and Their Potential Contribution to Neuropsychiatric Disorders.

Authors:  Callum J Young; David Lyons; Hugh D Piggins
Journal:  Front Behav Neurosci       Date:  2022-01-28       Impact factor: 3.558

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.